Search

Author/Creator Clotet, B

1. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort. Issue 4 (22nd December 2017)

Authors:
Roen, A; Laut, K; Pelchen‐Matthews, A; Borodulina, E; Caldeira, L; Clarke, A; Clotet, B; d'Arminio Monforte, A; Fätkenheuer, G; Gatell Artigas, JM; Karpov, I; Kuznetsova, A; Kyselyova, G; Mozer‐Lisewska, I; Mulcahy, F; Ragone, L; Scherrer, A; Uzdaviniene, V; Vandekerckhove, L; Vannappagari, V
Other Names:
Losso M. investigator.; Kundro M. investigator.; Schmied B. investigator.; Zangerle R. investigator.; Vassilenko A. investigator.; Mitsura V.M. investigator.; Paduto D. investigator.; Clumeck N. investigator.; De Wit S. investigator.; Delforge M. investigator.; Florence E. investigator.; Hadziosm...
Journal:
HIV medicine
Issue:
Volume 19:Issue 4(2018)
Page Start:
252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of two different strategies of treatment with zoledronate in HIV‐infected patients with low bone mineral density: single dose versus two doses in 2 years. Issue 7 (6th May 2015)

Authors:
Negredo, E; Bonjoch, A; Pérez‐Álvarez, N; Ornelas, A; Puig, J; Herrero, C; Estany, C; del Río, L; di Gregorio, S; Echeverría, P; Clotet, B
Journal:
HIV medicine
Issue:
Volume 16:Issue 7(2015:Aug.)
Page Start:
441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data1. Issue 5 (14th January 2015)

Authors:
Vingerhoets, J; Calvez, V; Flandre, P; Marcelin, A‐G; Ceccherini‐Silberstein, F; Perno, C‐F; Mercedes Santoro, M; Bateson, R; Nelson, M; Cozzi‐Lepri, A; Grarup, J; Lundgren, J; Incardona, F; Kaiser, R; Sonnerborg, A; Clotet, B; Paredes, R; Günthard, HF; Ledergerber, B; Hoogstoel, A
Journal:
HIV medicine
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
297
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. Issue 6 (9th January 2013)

Authors:
Ribera, E; Larrousse, M; Curran, A; Negredo, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Ferrer, P; Alvarez, ML; Arterburn, S; Martínez, E
Journal:
HIV medicine
Issue:
Volume 14:Issue 6(2013:Jul.)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. Issue 4 (19th November 2013)

Authors:
Sanmartín, R; Tor, J; Sanvisens, A; López, JJ; Jou, A; Muga, R; Ojanguren, I; Barluenga, E; Videla, S; Planas, R; Clotet, B; Tural, C
Journal:
HIV medicine
Issue:
Volume 15:Issue 4(2014:Apr.)
Page Start:
203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗